RAFAEL HOLDINGS, INC. Interest Expense
RAFAEL HOLDINGS, INC. (RFL) reported Interest Expense of $160.00 thousand for the 3-month period ending 2025-10-31, per its 10-Q filed 2025-12-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-12-12
- RAFAEL HOLDINGS, INC. interest expense for the quarter ending 2025-10-31 was $160.00K, a 1.23% decline year-over-year.
- RAFAEL HOLDINGS, INC. interest expense for the quarter ending 2025-07-31 was $168.00K, a 3.07% increase year-over-year.
- RAFAEL HOLDINGS, INC. interest expense for the quarter ending 2025-04-30 was $165.00K, a 94.12% increase year-over-year.
- RAFAEL HOLDINGS, INC. interest expense for the quarter ending 2025-01-31 was $163.00K.
- RAFAEL HOLDINGS, INC. interest expense for fiscal 2025 was $658.00K, a 165.32% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. interest expense for fiscal 2024 was $248.00K.
- RAFAEL HOLDINGS, INC. interest expense for fiscal 2022 was $6.00K, a 50.00% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. interest expense for fiscal 2021 was $12.00K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-10-31 | $160.00K 10-Q · filed 2025-12-12 | $328.00K derived: sum of 2 quarters · filed 2025-12-12 | $493.00K derived: sum of 3 quarters · filed 2025-12-12 | $656.00K derived: sum of 4 quarters · filed 2025-12-12 | ||
| 2025-07-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $333.00K derived: sum of 2 quarters · filed 2025-10-29 | $496.00K derived: sum of 3 quarters · filed 2025-10-29 | $658.00K 10-K · filed 2025-10-29 | ||
| 2025-04-30 | $165.00K 10-Q · filed 2025-06-11 | $328.00K derived: sum of 2 quarters · filed 2025-06-11 | $490.00K 10-Q · filed 2025-06-11 | $653.00K derived: sum of 4 quarters · filed 2025-12-12 | ||
| 2025-01-31 | $163.00K 10-Q · filed 2025-03-14 | $325.00K 10-Q · filed 2025-03-14 | $488.00K derived: sum of 3 quarters · filed 2025-12-12 | $573.00K derived: sum of 4 quarters · filed 2025-12-12 | ||
| 2024-10-31 | $162.00K 10-Q · filed 2025-12-12 | $325.00K derived: sum of 2 quarters · filed 2025-12-12 | $410.00K derived: sum of 3 quarters · filed 2025-12-12 | |||
| 2024-07-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $248.00K derived: sum of 2 quarters · filed 2025-10-29 | $248.00K 10-K · filed 2025-10-29 | |||
| 2024-04-30 | $85.00K 10-Q · filed 2025-06-11 | $85.00K 10-Q · filed 2025-06-11 | ||||
| 2022-07-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$12.00K derived: sum of 2 quarters · filed 2023-10-30 | -$12.00K derived: sum of 3 quarters · filed 2023-10-30 | $6.00K 10-K · filed 2023-10-30 | ||
| 2022-04-30 | $1.00K 10-Q · filed 2023-06-13 | $399.00K 10-Q · filed 2022-06-14 | $1.00K derived: sum of 2 quarters · filed 2023-06-13 | $19.00K 10-Q · filed 2023-06-13 | $1.21M 10-Q · filed 2022-06-14 | $21.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $13.00K 10-Q · filed 2023-03-14 | $20.00K derived: sum of 3 quarters · filed 2023-03-14 | $23.00K derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-10-31 | $13.00K 10-Q · filed 2022-12-13 | $20.00K derived: sum of 2 quarters · filed 2022-12-13 | $23.00K derived: sum of 3 quarters · filed 2022-12-13 | |||
| 2021-07-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $10.00K derived: sum of 2 quarters · filed 2022-10-31 | $12.00K 10-K · filed 2022-10-31 | |||
| 2021-04-30 | $3.00K 10-Q · filed 2022-06-14 | $5.00K 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |